Fluticasone/salm Inh 230/21mcg 120s

Manufacturer PRASCO LABORATORIES Active Ingredient Fluticasone and Salmeterol Inhaler(floo TIK a sone & sal ME te role) Pronunciation floo TIK a sone & sal ME te role
It is used to treat asthma.Do not use this drug to treat intense flare-ups of shortness of breath. Use a rescue inhaler. If you have questions, talk with the doctor.
🏷️
Drug Class
Antiasthmatic; Bronchodilator, Beta-2 Agonist; Corticosteroid, Inhalant
🧬
Pharmacologic Class
Corticosteroid; Long-acting Beta2-adrenergic Agonist (LABA)
🀰
Pregnancy Category
C
βœ…
FDA Approved
Aug 2000
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medication is an inhaler that contains two medicines: a corticosteroid (fluticasone) to reduce inflammation in your lungs and a long-acting bronchodilator (salmeterol) to help open your airways. It's used twice a day to help prevent asthma attacks and improve breathing in people with COPD. It is not for sudden breathing problems.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To use this medication safely and effectively, follow your doctor's instructions and the information provided with your prescription. Use this inhaler only for breathing in, as directed by your healthcare provider. Continue using this medication even if you feel well, and take it at the same time every day.

After each use, rinse your mouth with water and spit it out - do not swallow the rinse water. If you are using multiple inhaled medications, consult your doctor about which one to use first.

Preparing and Using Your Inhaler

Before using your inhaler for the first time, shake it well and spray 4 test sprays into the air, away from your face. If you haven't used your inhaler in over 4 weeks or if it's been dropped, shake it well and spray 2 test sprays into the air, away from your face, before using it again. Always replace the cap after taking your dose.

Important Safety Precautions

This medication is flammable, so do not use it near an open flame or while smoking. Some inhalers have a dose counter to track the number of doses remaining. If your inhaler has a dose counter, dispose of it when the counter reaches "0".

Storing and Disposing of Your Medication

Store your inhaler at room temperature in a dry place, away from bathrooms. Keep the mouthpiece facing down.

Missing a Dose

If you miss a dose, skip it and take your next dose at the usual time. Do not take two doses at once or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Use regularly, even if you feel well, to get the full benefit.
  • Rinse your mouth with water and spit it out after each dose to prevent oral thrush (yeast infection). Do not swallow the water.
  • Do not use for sudden breathing problems; always carry a fast-acting rescue inhaler (e.g., albuterol) for acute symptoms.
  • Do not exceed the prescribed dose or use more often than twice daily.
  • Avoid triggers that worsen your asthma or COPD (e.g., smoke, allergens, air pollution).
  • Maintain good hydration and nutrition.
  • Regular exercise as tolerated and advised by your doctor.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 1 inhalation (Fluticasone 230 mcg/Salmeterol 21 mcg) twice daily, approximately 12 hours apart
Dose Range: 230 - 230 mg

Condition-Specific Dosing:

asthmaMaintenance: 1 inhalation (230/21 mcg) twice daily
COPDMaintenance: 1 inhalation (230/21 mcg) twice daily
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not recommended for children under 12 years for this strength. Lower strengths (e.g., 100/50 mcg, 250/50 mcg) are available for children 12 years and older for asthma.
Adolescent: For asthma (β‰₯12 years): 1 inhalation (230/21 mcg) twice daily if higher dose of fluticasone propionate is required.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment necessary
Moderate: No dosage adjustment necessary
Severe: No dosage adjustment necessary
Dialysis: No specific recommendations; monitor for systemic effects if severe impairment

Hepatic Impairment:

Mild: No dosage adjustment necessary
Moderate: Use with caution; monitor for increased systemic corticosteroid effects due to potential for increased fluticasone exposure
Severe: Use with caution; monitor for increased systemic corticosteroid effects due to potential for increased fluticasone exposure

Pharmacology

πŸ”¬

Mechanism of Action

Fluticasone propionate is a synthetic trifluorinated corticosteroid with potent anti-inflammatory activity. It reduces inflammation in the airways by inhibiting multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, cytokines) involved in allergic and non-allergic mediated inflammation. Salmeterol xinafoate is a long-acting beta2-adrenergic agonist (LABA). It selectively stimulates beta2-adrenergic receptors in the lungs, leading to relaxation of bronchial smooth muscle and bronchodilation. The long duration of action is due to its lipophilicity, allowing it to bind to an 'exosite' on the receptor, providing continuous stimulation.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Fluticasone: ~1% (oral), ~30% (pulmonary); Salmeterol: Low systemic absorption from inhaled dose
Tmax: Fluticasone: 0.5-1 hour; Salmeterol: 5-10 minutes
FoodEffect: Not applicable for inhaled administration

Distribution:

Vd: Fluticasone: ~318 L; Salmeterol: ~15.6 L/kg
ProteinBinding: Fluticasone: 91%; Salmeterol: 96%
CnssPenetration: Limited

Elimination:

HalfLife: Fluticasone: ~7.8 hours (terminal); Salmeterol: ~5.5 hours (terminal)
Clearance: Fluticasone: ~1150 mL/min; Salmeterol: ~1200 mL/min
ExcretionRoute: Fluticasone: Feces (primarily); Salmeterol: Feces (primarily), Urine
Unchanged: Fluticasone: <5% (urine); Salmeterol: <1% (urine)
⏱️

Pharmacodynamics

OnsetOfAction: Salmeterol: 10-20 minutes (significant bronchodilation); Fluticasone: Days to weeks for full anti-inflammatory effect
PeakEffect: Salmeterol: 2-4 hours; Fluticasone: 1-2 weeks for maximal therapeutic benefit
DurationOfAction: Salmeterol: 12 hours; Fluticasone: Dose-dependent, sustained anti-inflammatory effect

Safety & Warnings

⚠️

BLACK BOX WARNING

Long-acting beta2-adrenergic agonists (LABAs), such as salmeterol, increase the risk of asthma-related death. Data from a large, randomized, placebo-controlled clinical trial in asthma showed that LABAs increase the risk of asthma-related death. This finding is considered a class effect of LABAs. The safety and effectiveness of Fluticasone Propionate and Salmeterol Inhalation Powder in patients with asthma have not been established in children less than 4 years of age. Fluticasone Propionate and Salmeterol Inhalation Powder is NOT indicated for the relief of acute bronchospasm.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction: rash, hives, itching, red, swollen, blistered, or peeling skin (with or without fever), wheezing, tightness in the chest or throat, difficulty breathing, swallowing, or talking, unusual hoarseness, or swelling of the mouth, face, lips, tongue, or throat
Signs of infection: fever, chills, severe sore throat, ear or sinus pain, cough, increased or changed sputum production, painful urination, mouth sores, or a wound that won't heal
Signs of high blood sugar: confusion, drowsiness, excessive thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath
Signs of low potassium levels: muscle pain or weakness, muscle cramps, or an irregular heartbeat
Signs of a weak adrenal gland: severe nausea or vomiting, extreme dizziness or fainting, muscle weakness, fatigue, mood changes, decreased appetite, or weight loss
Signs of high or low blood pressure: severe headache or dizziness, fainting, or changes in vision
Chest pain or pressure
Rapid or abnormal heartbeat
Shakiness
Feeling nervous or agitated
Changes in behavior
Vision changes, eye pain, or severe eye irritation
Abnormal burning, numbness, or tingling sensations
Choking
Voice changes
Seizures
Bone pain
Sleep disturbances
Feeling extremely tired or weak
Vaginal itching or discharge
Weight gain
Mouth irritation or mouth sores
Redness or white patches in the mouth or throat

Important: This medication can cause severe breathing problems, which may be life-threatening. If you experience difficulty breathing, worsening breathing, wheezing, or coughing after taking this medication, use a rescue inhaler and seek immediate medical attention.

Other Possible Side Effects

Most medications can cause side effects, but many people experience none or only mild symptoms. If you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention if they bother you or persist:

Headache
Nausea or vomiting
Throat irritation
* Common cold symptoms

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening shortness of breath or wheezing
  • Increased need for your rescue inhaler
  • Chest pain or fast/pounding heartbeat
  • Severe headache
  • Signs of infection (fever, chills, increased mucus, change in mucus color)
  • White patches in your mouth or throat (oral thrush)
  • Blurred vision or eye pain
  • Swelling of your face, lips, or tongue (allergic reaction)
  • Muscle cramps or weakness
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking a similar medication. If you are unsure, consult your doctor or pharmacist for clarification.
Any prescription or over-the-counter (OTC) medications, natural products, or vitamins you are taking that may interact with this medication. Certain medications used to treat HIV, infections, depression, and other conditions should not be taken with this drug. Your doctor or pharmacist can advise you on potential interactions.
Please note that this is not an exhaustive list of all medications or health conditions that may interact with this drug.

To ensure your safety, it is crucial to discuss the following with your doctor and pharmacist:

All medications you are taking, including prescription and OTC medications, natural products, and vitamins.
Any health problems you have.
* You must verify that it is safe to take this medication with all your other medications and health conditions. Do not start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. You may not experience the full effects of this drug for approximately 1 week.

If you have diabetes (high blood sugar), consult with your doctor, as this medication may increase your blood sugar levels. Immediately contact your doctor if your breathing problems worsen, your rescue inhaler becomes less effective, or you need to use it more frequently.

Do not exceed the recommended dose or use this medication more often than prescribed. Overdosing on this type of medication has been fatal. Consult with your doctor if you have any concerns.

When transitioning from an oral steroid to a different form of steroid, you may be at risk for severe and potentially life-threatening side effects. Be aware of symptoms such as weakness, fatigue, dizziness, nausea, vomiting, confusion, or low blood sugar, and contact your doctor immediately if you experience any of these.

In the event of a severe injury, surgery, or infection, you may require additional doses of oral steroids to help your body cope with the stress. Carry a warning card indicating that you may need extra steroids in certain situations.

Long-term use of this medication may increase your risk of developing cataracts or glaucoma. Discuss this with your doctor and follow their recommendations for regular eye exams.

Prolonged use of this medication may also lead to osteoporosis (weak bones). Consult with your doctor to determine your risk and address any concerns. Follow your doctor's advice regarding bone density tests.

You may be more susceptible to infections while taking this medication. To minimize this risk, practice good hygiene by washing your hands frequently and avoid close contact with people who have infections, colds, or flu.

If you have not previously had chickenpox or measles, avoid exposure to these illnesses, as they can be severe or even fatal in people taking steroid medications like this one. If you have been exposed to chickenpox or measles, consult with your doctor.

If you are 65 or older, use this medication with caution, as you may be more prone to side effects.

In some cases, this medication may affect growth in children and teenagers. Regular growth checks may be necessary, so discuss this with your doctor.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor to discuss the potential benefits and risks to you and your baby.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Chest pain
  • Fast or irregular heartbeat (palpitations)
  • Tremor or nervousness
  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Muscle cramps
  • Seizures
  • Hypokalemia (low potassium)
  • Hyperglycemia (high blood sugar)
  • Exaggerated systemic corticosteroid effects (e.g., Cushing's syndrome symptoms, adrenal suppression) with chronic overdose

What to Do:

Seek immediate medical attention or call Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic. May involve cardiac monitoring, potassium supplementation, and glucose management.

Drug Interactions

🚫

Contraindicated Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin)
πŸ”΄

Major Interactions

  • Beta-blockers (non-cardioselective)
  • Diuretics (thiazide or loop) - potential for hypokalemia
  • Tricyclic antidepressants (TCAs)
  • Monoamine oxidase inhibitors (MAOIs)
  • Other long-acting beta2-agonists (LABAs)
🟑

Moderate Interactions

  • Other adrenergic drugs
  • QTc-prolonging drugs
  • Xanthine derivatives (e.g., theophylline)
  • Corticosteroids (systemic)
🟒

Minor Interactions

  • Not specifically identified as minor, but general caution with drugs affecting electrolyte balance.

Monitoring

πŸ”¬

Baseline Monitoring

Pulmonary function tests (FEV1, FVC)

Rationale: To establish baseline lung function and assess disease severity.

Timing: Prior to initiation of therapy

Asthma/COPD symptom control assessment

Rationale: To establish baseline symptom frequency and severity.

Timing: Prior to initiation of therapy

Growth (in pediatric patients)

Rationale: To monitor for potential systemic corticosteroid effects on growth.

Timing: Prior to initiation of therapy

Ophthalmologic exam (for high-risk patients)

Rationale: To screen for cataracts or glaucoma, especially with long-term ICS use.

Timing: Prior to initiation of therapy, if indicated

πŸ“Š

Routine Monitoring

Pulmonary function tests (FEV1)

Frequency: Periodically (e.g., every 3-12 months or as clinically indicated)

Target: Improvement from baseline, maintenance of optimal lung function

Action Threshold: Worsening FEV1, lack of improvement

Asthma/COPD symptom control

Frequency: At each follow-up visit (e.g., every 1-3 months initially, then every 3-12 months)

Target: Reduced frequency of symptoms, reduced need for rescue medication

Action Threshold: Increased symptoms, increased rescue inhaler use, nocturnal awakenings

Adverse effects (e.g., oral candidiasis, dysphonia, tremor, palpitations)

Frequency: At each follow-up visit

Target: Absence or minimal adverse effects

Action Threshold: Persistent or worsening adverse effects

Growth (in pediatric patients)

Frequency: Regularly (e.g., every 3-6 months)

Target: Normal growth velocity for age

Action Threshold: Growth deceleration

Serum potassium (if risk factors for hypokalemia)

Frequency: As clinically indicated

Target: 3.5-5.0 mEq/L

Action Threshold: <3.5 mEq/L

Blood glucose (if risk factors for hyperglycemia)

Frequency: As clinically indicated

Target: Normal fasting glucose

Action Threshold: Elevated glucose

πŸ‘οΈ

Symptom Monitoring

  • Increased shortness of breath
  • Increased wheezing
  • Increased cough
  • Increased need for rescue inhaler (e.g., albuterol)
  • Worsening of asthma/COPD symptoms at night
  • Chest tightness
  • Signs of oral thrush (white patches in mouth/throat)
  • Hoarseness or voice changes
  • Tremor or nervousness
  • Palpitations or rapid heart rate
  • Muscle cramps or weakness (potential hypokalemia)
  • Blurred vision or eye pain (potential for glaucoma/cataracts)

Special Patient Groups

🀰

Pregnancy

Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Asthma control is important during pregnancy. Category C.

Trimester-Specific Risks:

First Trimester: Limited data, but generally, uncontrolled asthma poses greater risk than medication.
Second Trimester: No specific increased risks identified beyond general Category C considerations.
Third Trimester: No specific increased risks identified beyond general Category C considerations. Monitor for potential effects on fetal adrenal function with high doses of corticosteroids.
🀱

Lactation

Caution should be exercised when administered to a nursing woman. Fluticasone and salmeterol are present in human milk. Consider the developmental and health benefits of breastfeeding along with the mother’s clinical need for the drug and any potential adverse effects on the breastfed infant.

Infant Risk: L3 (Moderate concern). Potential for systemic effects in the infant, though levels are likely low due to poor oral bioavailability of fluticasone and extensive metabolism of salmeterol. Monitor for signs of adrenal suppression or beta-adrenergic effects in the infant.
πŸ‘Ά

Pediatric Use

Not indicated for children under 12 years for this specific strength (230/21 mcg). Lower strengths are approved for children 12 years and older with asthma. Monitor growth velocity in pediatric patients receiving inhaled corticosteroids.

πŸ‘΄

Geriatric Use

No overall differences in safety or effectiveness have been observed between elderly and younger patients. However, elderly patients may be more susceptible to the effects of beta2-agonists (e.g., cardiovascular effects) and corticosteroids (e.g., bone density, cataracts, glaucoma). Use with caution and monitor closely.

Clinical Information

πŸ’Ž

Clinical Pearls

  • This combination inhaler is for maintenance therapy only and should not be used for acute bronchospasm. Patients should always have a short-acting beta2-agonist (SABA) for rescue.
  • Proper inhaler technique is crucial for efficacy. Patients should be instructed on how to use the Diskus device correctly.
  • Rinsing the mouth after each dose helps prevent oral candidiasis (thrush) and dysphonia.
  • Patients should be advised not to stop therapy abruptly, especially if on high doses, due to the risk of adrenal insufficiency.
  • The black box warning for LABAs applies, emphasizing that this product should not be used as monotherapy for asthma and is generally reserved for patients whose asthma is not adequately controlled on an ICS alone or whose disease severity warrants initiation of both an ICS and LABA.
  • Monitor for systemic corticosteroid effects, especially with prolonged use of high doses (e.g., adrenal suppression, bone mineral density changes, cataracts, glaucoma, hyperglycemia).
πŸ”„

Alternative Therapies

  • Inhaled Corticosteroids (ICS) monotherapy (e.g., fluticasone propionate, budesonide, mometasone)
  • Long-acting Muscarinic Antagonists (LAMAs) (e.g., tiotropium, umeclidinium) - primarily for COPD, sometimes add-on for asthma
  • Leukotriene Receptor Antagonists (LTRAs) (e.g., montelukast)
  • Oral corticosteroids (for severe exacerbations or refractory disease)
  • Biologic therapies (e.g., omalizumab, mepolizumab, dupilumab) for severe asthma
πŸ’°

Cost & Coverage

Average Cost: $300 - $600 per 120 actuations inhaler
Generic Available: Yes
Insurance Coverage: Tier 2 or Tier 3 (preferred brand or non-preferred brand, generic often Tier 1)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.